{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:04:30Z","timestamp":1789610670776,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yixiao He","award":["GTCZ-2023-SC-04"],"award-info":[{"award-number":["GTCZ-2023-SC-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05501-3","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:24:40Z","timestamp":1782818680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of primary prostatic intravascular large B-cell lymphoma misdiagnosed as benign prostatic hyperplasia"],"prefix":"10.1007","volume":"17","author":[{"given":"Lili","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"3","key":"5501_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4103\/ijpm.ijpm_324_20","volume":"64","author":"HB Rallabandi","year":"2021","unstructured":"Rallabandi HB, Thirukovela J, Swain M, Meeramira D, Gowrishankar S, Intravascular large B. cell lymphoma of prostate, a rare entity. Indian J Pathol Microbiol. 2021;64(3):575\u20138. https:\/\/doi.org\/10.4103\/ijpm.ijpm_324_20","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"5501_CR2","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s12672-025-04141-3","volume":"16","author":"J Zhao","year":"2025","unstructured":"Zhao J, Li L, Yang J, Peng J, Li C. Clinical and pathological analysis of intravascular large B-Cell lymphoma of the prostate. Discover Oncol. 2025;16(1):2193. https:\/\/doi.org\/10.1007\/s12672-025-04141-3","journal-title":"Discover Oncol"},{"issue":"11","key":"5501_CR3","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.annonc.2025.07.014","volume":"36","author":"TA Eyre","year":"2025","unstructured":"Eyre TA, Cwynarski K, d\u2019Amore F, de Leval L, Dreyling M, Eichenauer DA, et al. Lymphomas: Esmo Clinical practice guideline for diagnosis, treatment and follow-up. Annals oncology: official J Eur Soc Med Oncol. 2025;36(11):1263\u201384. https:\/\/doi.org\/10.1016\/j.annonc.2025.07.014","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"issue":"9","key":"5501_CR4","first-page":"4117","volume":"32","author":"B Nojkov","year":"2012","unstructured":"Nojkov B, Signori C, Konda A, Fontana RJ. Lenalidomide-Associated hepatotoxicity\u2013a case report and literature review. Anticancer Res. 2012;32(9):4117\u20139.","journal-title":"Anticancer Res"},{"issue":"1","key":"5501_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12876-021-01825-2","volume":"21","author":"E Atallah","year":"2021","unstructured":"Atallah E, Wijayasiri P, Cianci N, Abdullah K, Mukherjee A, Aithal GP. Zanubrutinib-induced liver injury: a case report and literature review. BMC Gastroenterol. 2021;21(1):244. https:\/\/doi.org\/10.1186\/s12876-021-01825-2","journal-title":"BMC Gastroenterol"},{"key":"5501_CR6","doi-asserted-by":"publisher","unstructured":"Armendariz-Pineda SM, Vargas-Beltran AM, Corredor-Nassar MJ, Gamboa-Dom\u00ednguez A, Santos-Reyes DA, Cordova-Gallardo J. Drug-Induced Liver Injury Secondary to Rituximab Use. Oxford medical case reports 2025;2025(7):omaf003. https:\/\/doi.org\/10.1093\/omcr\/omaf003","DOI":"10.1093\/omcr\/omaf003"},{"issue":"2","key":"5501_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/s0046-8177(00)80223-3","volume":"31","author":"M Ponzoni","year":"2000","unstructured":"Ponzoni M, Arrigoni G, Gould VE, Del Curto B, Maggioni M, Scapinello A, et al. Lack of Cd 29 (Beta1 Integrin) and Cd 54 (Icam-1) Adhesion Molecules in Intravascular Lymphomatosis. Hum Pathol. 2000;31(2):220\u20136. https:\/\/doi.org\/10.1016\/s0046-8177(00)80223-3","journal-title":"Hum Pathol"},{"issue":"15","key":"5501_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N Engl J Med. 2018;378(15):1396\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1801445","journal-title":"N Engl J Med"},{"issue":"11","key":"5501_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1182\/blood.2020007245","volume":"137","author":"K Shimada","year":"2021","unstructured":"Shimada K, Yoshida K, Suzuki Y, Iriyama C, Inoue Y, Sanada M, et al. Frequent Genetic Alterations in Immune Checkpoint-Related Genes in Intravascular Large B-Cell Lymphoma. Blood. 2021;137(11):1491\u2013502. https:\/\/doi.org\/10.1182\/blood.2020007245","journal-title":"Blood"},{"issue":"15","key":"5501_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1182\/blood-2017-04-737445","volume":"132","author":"M Ponzoni","year":"2018","unstructured":"Ponzoni M, Campo E, Nakamura S, Intravascular Large B-C, Lymphoma. A Chameleon with Multiple Faces and Many Masks. Blood. 2018;132(15):1561\u20137. https:\/\/doi.org\/10.1182\/blood-2017-04-737445","journal-title":"Blood"},{"key":"5501_CR11","doi-asserted-by":"publisher","unstructured":"Shiroshita K, Kikuchi T, Okayama M, Kasahara H, Kamiya T, Shimizu T et al. Interleukin-6-Producing Intravascular Large B-Cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease. Internal medicine (Tokyo, Japan) 2020;59(23):3061\u20135. https:\/\/doi.org\/10.2169\/internalmedicine.5046-20","DOI":"10.2169\/internalmedicine.5046-20"},{"issue":"4","key":"5501_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/1066896911408721","volume":"19","author":"M Xu","year":"2011","unstructured":"Xu M, Yang Q, Li M, Geng W, Huang W, Chen Y. Prostate Involvement by Intravascular Large B-Cell Lymphoma: A Case Report with Literature Review. Int J Surg Pathol. 2011;19(4):544\u20137. https:\/\/doi.org\/10.1177\/1066896911408721","journal-title":"Int J Surg Pathol"},{"issue":"19","key":"5501_CR13","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1200\/jco.2007.15.4278","volume":"26","author":"K Shimada","year":"2008","unstructured":"Shimada K, Matsue K, Yamamoto K, Murase T, Ichikawa N, Okamoto M, et al. Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy as Reported by the Ivl Study Group in Japan. J Clin oncology: official J Am Soc Clin Oncol. 2008;26(19):3189\u201395. https:\/\/doi.org\/10.1200\/jco.2007.15.4278","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"issue":"2","key":"5501_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","volume":"127","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular Lymphoma: Clinical Presentation, Natural History, Management and Prognostic Factors in a Series of 38 Cases, with Special Emphasis on the \u2018Cutaneous Variant\u2019. Br J Haematol. 2004;127(2):173\u201383. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05177.x","journal-title":"Br J Haematol"},{"issue":"4","key":"5501_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4274\/tjh.2013.0090","volume":"31","author":"N \u00d6zsan","year":"2014","unstructured":"\u00d6zsan N, Sars\u0131k B, Y\u0131lmaz AF, \u015eim\u015fir A, D\u00f6nmez A. Intravascular Large B-Cell Lymphoma Diagnosed on Prostate Biopsy: A Case Report. Turkish J haematology: official J Turkish Soc Haematol. 2014;31(4):403\u20137. https:\/\/doi.org\/10.4274\/tjh.2013.0090","journal-title":"Turkish J haematology: official J Turkish Soc Haematol"},{"issue":"31","key":"5501_CR16","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1200\/jco.2008.19.1841","volume":"26","author":"AJ Ferreri","year":"2008","unstructured":"Ferreri AJ, Dognini GP, Govi S, Crocchiolo R, Bouzani M, Bollinger CR, et al. Can Rituximab Change the Usually Dismal Prognosis of Patients with Intravascular Large B-Cell Lymphoma? J Clin oncology: official J Am Soc Clin Oncol. 2008;26(31):5134\u20136. https:\/\/doi.org\/10.1200\/jco.2008.19.1841","journal-title":"J Clin oncology: official J Am Soc Clin Oncol"},{"key":"5501_CR17","doi-asserted-by":"publisher","unstructured":"Ogasawara T, Ikehata Y, Kato R, Miyao N, Konishi Y, Kon S. A Rare case of suspected intravascular Large B-cell lymphoma forming nodular masses in the brain and around the prostate and seminal vesicle. Urol Case Rep. 2018;18(22\u20135). https:\/\/doi.org\/10.1016\/j.eucr.2018.02.002","DOI":"10.1016\/j.eucr.2018.02.002"},{"issue":"6","key":"5501_CR18","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.12788\/jcso.0425","volume":"16","author":"A Mukherjee","year":"2018","unstructured":"Mukherjee A, Ibrahim IF, Intravascular Large B-C. Lymphoma: An Elusive Diagnosis with Challenging Management. J community supportive Oncol. 2018;16(6):e280\u20132. https:\/\/doi.org\/10.12788\/jcso.0425. Epub 2018\/01\/01.","journal-title":"J community supportive Oncol"},{"issue":"21","key":"5501_CR19","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1182\/blood.2025028649","volume":"146","author":"PP Xu","year":"2025","unstructured":"Xu PP, Zhu Y, Shi ZY, Wang L, Cheng S, Qian Y, et al. A Phase 2 study of Zanubrutinib in combination with rituximab and lenalidomide in De Novo Diffuse large B-cell lymphoma. Blood. 2025;146(21):2561\u201373. https:\/\/doi.org\/10.1182\/blood.2025028649","journal-title":"Blood"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05501-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:47:02Z","timestamp":1789609622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05501-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5501"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05501-3","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Biomedical Ethics Committee of Mianyang Central Hospital (Approval No. S202503216-01). The protocol was reviewed and approved in accordance with the guidelines of the committee and the principles of the Declaration of Helsinki. Written informed consent to participate was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and any accompanying images was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1338"}}